EODData

MEMBERSHIP REGISTER LOG IN

NYSE, IQV: Iqvia Holdings Inc

11 Nov 25 16:56
LAST:

218.5

CHANGE:
 5.48		OPEN:
214.4		HIGH:
220.1		ASK:
0.0		VOLUME:
1.45M
CHG(%):
2.57		PREV:
213.1		LOW:
213.5		BID:
0.0		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
11 Nov 25214.4220.1213.5218.51.45M
10 Nov 25213.2214.4210.3213.11.06M
07 Nov 25209.8211.3206.7210.51.16M
06 Nov 25210.0212.7208.8210.91.99M
05 Nov 25209.8212.1207.0210.11.51M
04 Nov 25210.9215.9209.1211.01.45M
03 Nov 25212.4215.4208.2213.92.07M
31 Oct 25216.3218.5214.1216.51.53M
30 Oct 25216.0220.2216.0216.51.76M
29 Oct 25220.0222.6215.7217.82.78M

COMPANY PROFILE

Name:Iqvia Holdings Inc
About:IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. It has a strategic collaboration with Sarah Cannon Research Institute to enhance clinical trial processes. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. The company is based in Durham, North Carolina.
Sector:Healthcare
Address:2400 Ellis Road, Durham, NC, United States, 27703
Website:https://www.iqvia.com
CUSIP:46266C105
CIK:0001478242
ISIN:US46266C1053
FIGI:BBG00333FYS2
LEI:549300W3R20NM4KQPH86

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:29.77 
Forward P/E:17.93 
PEG Ratio:-1.35 
Price to Sales:2.32 
Price to Book:5.98 
Profit Margin:0.08 
Operating Margin:0.14 
Return on Assets:0.05 
Return on Equity:0.19 
EPS Ratio:6.89 
Revenue:15.904B 
EBITDA:3.438B 
Shares:170.0M 
Market Cap:37.15B 

TECHNICAL INDICATORS

MA5:212.602.8%
MA10:213.862.2%
MA20:213.832.2%
MA50:200.459.0%
MA100:188.9115.7%
MA200:177.9322.8%
STO9:83.76 
STO14:56.52
RSI14:51.42
WPR14:-19.13 
MTM14:-1.38
ROC14:-0.01 
ATR:5.84 
Week High:220.130.7%
Week Low:206.725.7%
Month High:225.003.0%
Month Low:198.6422.8%
Year High:225.003.0%
Year Low:134.6562.3%